{"schema_version":"secwatch.filing_event.v1","accession":"0001299130-25-000015","form_type":"8-K","ticker":"PACB","cik":"0001299130","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.243736+00:00","generated_at":"2026-05-27T05:10:21.011085+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"PacBio appoints NeoGenomics CEO Chris Smith to board; David Meline resigns","bullets":["Chris Smith, CEO of NeoGenomics (NEO), appointed to PacBio Board effective Jan 30, 2025.","David Meline resigned from Board effective Jan 30, 2025; no disagreement cited.","Smith brings diagnostics and genomics expertise as PacBio expands into clinical genomics.","Smith previously led Ortho Clinical Diagnostics (sold to Quidel) and Cochlear Limited."],"urls":{"canonical":"https://secwatch.observer/filing/0001299130-25-000015","json":"https://secwatch.observer/filing/0001299130-25-000015.json","markdown":"https://secwatch.observer/filing/0001299130-25-000015.md","text":"https://secwatch.observer/filing/0001299130-25-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/0001299130-25-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/pacb-20250124.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T05:10:21.011085+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0fd64b22d3","claim":"Christopher M. Smith was appointed as Class III Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..","evidence_excerpt":"appointed Christopher M. Smith to serve as a Class III director effective January 30, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/0001299130-25-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"},{"claim_id":"4efd109b68","claim":"David Meline resigned as Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..","evidence_excerpt":"David Meline, a member of the Board, notified the Company of his resignation from the Board, effective January 30, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/0001299130-25-000015-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}